Selected research
Industry Research
NAD+ Intravenous Therapy Industry Research Report 2026
Market perspective
The global NAD+ Intravenous Therapy market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for NAD+ Intravenous Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for NAD+ Intravenous Therapy is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for NAD+ Intravenous Therapy is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of NAD+ Intravenous Therapy include Azivmedics, BioReset Medical, Conciergemdla, Effect Doctors, Hydrate IV Bar, IV Boost UK, LIVV Natural, Mobileivmedics and Nadclinic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global NAD+ Intravenous Therapy market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
NAD+ Intravenous Therapy Market by Company
Azivmedics
BioReset Medical
Conciergemdla
Effect Doctors
Hydrate IV Bar
IV Boost UK
LIVV Natural
Mobileivmedics
Nadclinic
Premiumhealth
Reset IV
Rocky Mountain Ivmedics
Seaside Skin Care
The Wellness Lab
Thedripclub
Toronto Functional Medicine Centre
NAD+ Intravenous Therapy Segment by Type
NAD+ Mixed Vitamin Injections
Pure NAD+ Injection
NAD+ Intravenous Therapy Segment by Application
Clinic
Hospital
Residential
NAD+ Intravenous Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Intravenous Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAD+ Intravenous Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Intravenous Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of NAD+ Intravenous Therapy manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of NAD+ Intravenous Therapy by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of NAD+ Intravenous Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Applications
- Clinic
- Hospital
- Residential
Companies covered
- Azivmedics
- BioReset Medical
- Conciergemdla
- Effect Doctors
- Hydrate IV Bar
- IV Boost UK
- LIVV Natural
- Mobileivmedics
- Nadclinic
- Premiumhealth
- Reset IV
- Rocky Mountain Ivmedics
- Seaside Skin Care
- The Wellness Lab
- Thedripclub
- Toronto Functional Medicine Centre
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global NAD+ Intravenous Therapy Market Size (2021-2032)
- 2.2.2 Global NAD+ Intravenous Therapy Sales (2021-2032)
- 2.2.3 Global NAD+ Intravenous Therapy Market Average Price (2021-2032)
- 2.3 NAD+ Intravenous Therapy by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 NAD+ Mixed Vitamin Injections
- 2.3.3 Pure NAD+ Injection
- 2.4 NAD+ Intravenous Therapy by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Residential
3 Market Competitive Landscape by Manufacturers
- 3.1 Global NAD+ Intravenous Therapy Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global NAD+ Intravenous Therapy Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global NAD+ Intravenous Therapy Revenue of Manufacturers (2021-2026)
- 3.4 Global NAD+ Intravenous Therapy Average Price by Manufacturers (2021-2026)
- 3.5 Global NAD+ Intravenous Therapy Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of NAD+ Intravenous Therapy, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of NAD+ Intravenous Therapy, Product Type & Application
- 3.8 Global Manufacturers of NAD+ Intravenous Therapy, Established Date
- 3.9 Global NAD+ Intravenous Therapy Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Azivmedics
- 4.1.1 Azivmedics Company Information
- 4.1.2 Azivmedics Business Overview
- 4.1.3 Azivmedics NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Azivmedics NAD+ Intravenous Therapy Product Portfolio
- 4.1.5 Azivmedics Recent Developments
- 4.2 BioReset Medical
- 4.2.1 BioReset Medical Company Information
- 4.2.2 BioReset Medical Business Overview
- 4.2.3 BioReset Medical NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BioReset Medical NAD+ Intravenous Therapy Product Portfolio
- 4.2.5 BioReset Medical Recent Developments
- 4.3 Conciergemdla
- 4.3.1 Conciergemdla Company Information
- 4.3.2 Conciergemdla Business Overview
- 4.3.3 Conciergemdla NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Conciergemdla NAD+ Intravenous Therapy Product Portfolio
- 4.3.5 Conciergemdla Recent Developments
- 4.4 Effect Doctors
- 4.4.1 Effect Doctors Company Information
- 4.4.2 Effect Doctors Business Overview
- 4.4.3 Effect Doctors NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Effect Doctors NAD+ Intravenous Therapy Product Portfolio
- 4.4.5 Effect Doctors Recent Developments
- 4.5 Hydrate IV Bar
- 4.5.1 Hydrate IV Bar Company Information
- 4.5.2 Hydrate IV Bar Business Overview
- 4.5.3 Hydrate IV Bar NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hydrate IV Bar NAD+ Intravenous Therapy Product Portfolio
- 4.5.5 Hydrate IV Bar Recent Developments
- 4.6 IV Boost UK
- 4.6.1 IV Boost UK Company Information
- 4.6.2 IV Boost UK Business Overview
- 4.6.3 IV Boost UK NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 IV Boost UK NAD+ Intravenous Therapy Product Portfolio
- 4.6.5 IV Boost UK Recent Developments
- 4.7 LIVV Natural
- 4.7.1 LIVV Natural Company Information
- 4.7.2 LIVV Natural Business Overview
- 4.7.3 LIVV Natural NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 LIVV Natural NAD+ Intravenous Therapy Product Portfolio
- 4.7.5 LIVV Natural Recent Developments
- 4.8 Mobileivmedics
- 4.8.1 Mobileivmedics Company Information
- 4.8.2 Mobileivmedics Business Overview
- 4.8.3 Mobileivmedics NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mobileivmedics NAD+ Intravenous Therapy Product Portfolio
- 4.8.5 Mobileivmedics Recent Developments
- 4.9 Nadclinic
- 4.9.1 Nadclinic Company Information
- 4.9.2 Nadclinic Business Overview
- 4.9.3 Nadclinic NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Nadclinic NAD+ Intravenous Therapy Product Portfolio
- 4.9.5 Nadclinic Recent Developments
- 4.10 Premiumhealth
- 4.10.1 Premiumhealth Company Information
- 4.10.2 Premiumhealth Business Overview
- 4.10.3 Premiumhealth NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Premiumhealth NAD+ Intravenous Therapy Product Portfolio
- 4.10.5 Premiumhealth Recent Developments
- 4.11 Reset IV
- 4.11.1 Reset IV Company Information
- 4.11.2 Reset IV Business Overview
- 4.11.3 Reset IV NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Reset IV NAD+ Intravenous Therapy Product Portfolio
- 4.11.5 Reset IV Recent Developments
- 4.12 Rocky Mountain Ivmedics
- 4.12.1 Rocky Mountain Ivmedics Company Information
- 4.12.2 Rocky Mountain Ivmedics Business Overview
- 4.12.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Product Portfolio
- 4.12.5 Rocky Mountain Ivmedics Recent Developments
- 4.13 Seaside Skin Care
- 4.13.1 Seaside Skin Care Company Information
- 4.13.2 Seaside Skin Care Business Overview
- 4.13.3 Seaside Skin Care NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Seaside Skin Care NAD+ Intravenous Therapy Product Portfolio
- 4.13.5 Seaside Skin Care Recent Developments
- 4.14 The Wellness Lab
- 4.14.1 The Wellness Lab Company Information
- 4.14.2 The Wellness Lab Business Overview
- 4.14.3 The Wellness Lab NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 The Wellness Lab NAD+ Intravenous Therapy Product Portfolio
- 4.14.5 The Wellness Lab Recent Developments
- 4.15 Thedripclub
- 4.15.1 Thedripclub Company Information
- 4.15.2 Thedripclub Business Overview
- 4.15.3 Thedripclub NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Thedripclub NAD+ Intravenous Therapy Product Portfolio
- 4.15.5 Thedripclub Recent Developments
- 4.16 Toronto Functional Medicine Centre
- 4.16.1 Toronto Functional Medicine Centre Company Information
- 4.16.2 Toronto Functional Medicine Centre Business Overview
- 4.16.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Product Portfolio
- 4.16.5 Toronto Functional Medicine Centre Recent Developments
5 Global NAD+ Intravenous Therapy Market Scenario by Region
- 5.1 Global NAD+ Intravenous Therapy Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global NAD+ Intravenous Therapy Sales by Region: 2021-2032
- 5.2.1 Global NAD+ Intravenous Therapy Sales by Region: 2021-2026
- 5.2.2 Global NAD+ Intravenous Therapy Sales by Region: 2027-2032
- 5.3 Global NAD+ Intravenous Therapy Revenue by Region: 2021-2032
- 5.3.1 Global NAD+ Intravenous Therapy Revenue by Region: 2021-2026
- 5.3.2 Global NAD+ Intravenous Therapy Revenue by Region: 2027-2032
- 5.4 North America NAD+ Intravenous Therapy Market Facts & Figures by Country
- 5.4.1 North America NAD+ Intravenous Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America NAD+ Intravenous Therapy Sales by Country (2021-2032)
- 5.4.3 North America NAD+ Intravenous Therapy Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe NAD+ Intravenous Therapy Market Facts & Figures by Country
- 5.5.1 Europe NAD+ Intravenous Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe NAD+ Intravenous Therapy Sales by Country (2021-2032)
- 5.5.3 Europe NAD+ Intravenous Therapy Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific NAD+ Intravenous Therapy Market Facts & Figures by Country
- 5.6.1 Asia Pacific NAD+ Intravenous Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific NAD+ Intravenous Therapy Sales by Country (2021-2032)
- 5.6.3 Asia Pacific NAD+ Intravenous Therapy Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America NAD+ Intravenous Therapy Market Facts & Figures by Country
- 5.7.1 South America NAD+ Intravenous Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America NAD+ Intravenous Therapy Sales by Country (2021-2032)
- 5.7.3 South America NAD+ Intravenous Therapy Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa NAD+ Intravenous Therapy Market Facts & Figures by Country
- 5.8.1 Middle East and Africa NAD+ Intravenous Therapy Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa NAD+ Intravenous Therapy Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa NAD+ Intravenous Therapy Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global NAD+ Intravenous Therapy Sales by Type (2021-2032)
- 6.1.1 Global NAD+ Intravenous Therapy Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global NAD+ Intravenous Therapy Sales Market Share by Type (2021-2032)
- 6.2 Global NAD+ Intravenous Therapy Revenue by Type (2021-2032)
- 6.2.1 Global NAD+ Intravenous Therapy Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global NAD+ Intravenous Therapy Revenue Market Share by Type (2021-2032)
- 6.3 Global NAD+ Intravenous Therapy Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global NAD+ Intravenous Therapy Sales by Application (2021-2032)
- 7.1.1 Global NAD+ Intravenous Therapy Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global NAD+ Intravenous Therapy Sales Market Share by Application (2021-2032)
- 7.2 Global NAD+ Intravenous Therapy Revenue by Application (2021-2032)
- 7.2.1 Global NAD+ Intravenous Therapy Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global NAD+ Intravenous Therapy Revenue Market Share by Application (2021-2032)
- 7.3 Global NAD+ Intravenous Therapy Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 NAD+ Intravenous Therapy Value Chain Analysis
- 8.1.1 NAD+ Intravenous Therapy Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 NAD+ Intravenous Therapy Production Mode & Process
- 8.2 NAD+ Intravenous Therapy Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 NAD+ Intravenous Therapy Distributors
- 8.2.3 NAD+ Intravenous Therapy Customers
9 Global NAD+ Intravenous Therapy Analyzing Market Dynamics
- 9.1 NAD+ Intravenous Therapy Industry Trends
- 9.2 NAD+ Intravenous Therapy Industry Drivers
- 9.3 NAD+ Intravenous Therapy Industry Opportunities and Challenges
- 9.4 NAD+ Intravenous Therapy Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst